Amundi Core Stoxx Europe 600 UCITS ETF Acc
LYP6.DE
Deutsche Börse- -
EUR
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 29-31 Adelaide Road Dublin Luxembourg D02 X281
- IPO Date
- Feb 19, 2024
- Website
- ishares.com
- Similar Companies
- Business
- Amundi Core Stoxx Europe 600 UCITS ETF Acc (LYP6.DE) is an exchange-traded fund that seeks to replicate, as closely as possible and whether the trend is rising or falling, the performance of the STOXX Europe 600 Index, a broad benchmark comprising the 600 largest European companies by free-float market capitalization across 17 European countries; the ETF employs a full physical replication strategy by holding all index constituents in their respective weightings, resulting in approximately 600 holdings with top exposures including ASML Holding NV, Roche Holding AG, AstraZeneca PLC, HSBC Holdings PLC, and Novartis AG; it features an accumulating distribution policy, reinvesting dividends to compound returns, a low total expense ratio of 0.07% p.a., and currency unhedged exposure in euros. The ETF, with assets under management exceeding EUR 14.5 billion as of late 2025, trades primarily under tickers LYP6 on Xetra, MEUD on Euronext Paris and the London Stock Exchange, and MEUS in other venues; it targets institutional and retail investors seeking diversified large-cap European equity exposure across sectors such as financials, health care, industrials, and consumer goods, with geographic focus on Eurozone countries, the United Kingdom, and Switzerland. Launched on April 3, 2013, and domiciled in Luxembourg as a UCITS-compliant SICAV structure, the ETF operates under the management of Amundi Asset Management, Europe's largest asset manager by assets under management. In recent years, the ETF has benefited from Amundi's 2021 acquisition of Lyxor Asset Management, which expanded its ETF lineup and led to subsequent product rationalizations including mergers of legacy Lyxor STOXX Europe 600 funds into Amundi-branded equivalents to achieve economies of scale and enhance liquidity; ongoing net asset value publications and regular fund flows reflect sustained investor interest, with AUM growth from approximately EUR 7.8 billion in mid-2024 to over EUR 14.5 billion by late 2025 amid favorable European equity market conditions.